四氟化铅(IV) | 7783-59-7

• 物质功能分类: 无机化工 - 无机盐 - 金属卤化物及卤酸盐
• 分子结构分类: 无机化合物 - 混合金属/非金属化合物 - 后过渡金属盐
• 中文名称: 四氟化铅(IV)
• 中文别名: 四氟化铅
• 英文名称: lead(IV) fluoride
• 英文别名: lead tetrafluoride；tetrafluoroplumbane
• CAS: 7783-59-7
• 化学式: F₄Pb
• 分子量: 283.194
• InChiKey: YAFKGUAJYKXPDI-UHFFFAOYSA-J

物化性质

• 熔点：
  600 °C
• 密度：
  6,7 g/cm3
• 暴露限值：
  ACGIH: TWA 0.05 mg/m3; TWA 2.5 mg/m3NIOSH: IDLH 100 mg/m3; IDLH 250 mg/m3; TWA 0.050 mg/m3
• 稳定性/保质期：

  如果按照规范进行使用和储存，则不会发生分解。

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  5
• 可旋转键数：
  0
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 危险等级：
  6.1
• 危险品标志：
  O,N-T,T,N
• 安全说明：
  S45,S53,S60,S61
• 危险类别码：
  R61,R33,R20/22,R50/53,R62
• 海关编码：
  28261990
• 危险品运输编号：
  UN 2291
• 包装等级：
  III
• 危险类别：
  6.1
• 储存条件：
  将食品存放在密封容器中，并放置在阴凉、干燥处。

SDS

Name:	Lead Tetrafluoride 99% Material Safety Data Sheet
Synonym:	PbF4; Lead Tetrafluoride
CAS:	7783-59-7

Section 1 - Chemical Product MSDS Name:Lead Tetrafluoride 99% Material Safety Data Sheet
Synonym:PbF4; Lead Tetrafluoride

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
7783-59-7	Lead Tetrafluoride	99	232-012-9

Hazard Symbols: T
Risk Phrases: 20/22 33 61 62

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation and if swallowed. Danger of cumulative effects. May cause harm to the unborn child. Possible risk of impaired fertility.Moisture sensitive.
Potential Health Effects
Eye:
May cause eye irritation. May cause visual disturbances.
Skin:
Causes skin irritation.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and diarrhea. Inorganic fluorides can be harmful. Acute exposure to fluorine compounds can lead to digestive tract burns, and abdominal pain. Exposure to fluoride compounds can result in systemic toxic effects on the heart, liver, and kidneys. It may also deplete calcium levels in the body leading to hypocalcemia and death.
Fluoride can reduce calcium levels leading to fatal hypocalcemia.
Ingestion of lead compounds can cause toxic effects in the blood-forming organs, kidneys and central nervous system. Symptoms of lead poisoning or plumbism include weakness, weight loss, lassitude, insomnia, and hypotension. It also includes constipation, anorexia, abdominal discomfort and colic. Symptoms of lead poisoning include; weakness, weight loss, lassitude, insomnia, and hypotension. Acute lead poisoning can cause muscle weakness, "lead line" on the gums, metallic taste, definite loss of appetite, insomnia, dizziness, high lead levels in blood and urine with shock, coma and death in extreme cases.
Inhalation:
May cause respiratory tract irritation. May cause effects similar to those described for ingestion.
Chronic:
Chronic inhalation and ingestion may cause chronic fluoride poisoning (fluorosis) characterized by weight loss, weakness, anemia, brittle bones, and stiff joints. Effects may be delayed.
Chronic exposure to lead may result in plumbism which is characterized by lead line in gum, headache, muscle weakness, mental changes. Chronic exposure to fluoride compounds may cause systemic toxicity. Chronic expsoure to lead may cause adverse effects on human reproduction, embryonic and fetal development and postnatal (e.g., mental) development.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Do not induce vomiting. If victim is conscious and alert, give 2-4 cupfuls of milk or water. Never give anything by mouth to an unconscious person. Get medical aid.
Inhalation:
Remove from exposure and move to fresh air immediately. If breathing is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth resuscitation. If breathing has ceased apply artificial respiration using oxygen and a suitable mechanical device such as a bag and a mask.
Notes to Physician:
Use of chelators such as BAL penicillamine and N-acetylpenicillamine should be considered.
Antidote: There exists several chelation agents. The determination of there use should be made only by qualified medical personnel.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use water spray to keep fire-exposed containers cool. Contact with metals may evolve flammable hydrogen gas. Containers may explode when heated.
Non-combustible, substance itself does not burn but may decompose upon heating to produce irritating, corrosive and/or toxic fumes.
Extinguishing Media:
Do NOT get water inside containers. For small fires, use dry chemical, carbon dioxide, or water spray. For large fires, use dry chemical, carbon dioxide, alcohol-resistant foam, or water spray.
Cool containers with flooding quantities of water until well after fire is out.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Avoid runoff into storm sewers and ditches which lead to waterways. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Wash hands before eating. Use only in a well-ventilated area. Minimize dust generation and accumulation.
Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation. Wash clothing before reuse.
Storage:
Keep from contact with oxidizing materials. Store in a cool, dry, well-ventilated area away from incompatible substances. Keep containers tightly closed.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels below recommended exposure limits. Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower.
Exposure Limits CAS# 7783-59-7: United Kingdom, WEL - TWA: (listed as fluorides, inorganic): 2.5 mg/m3 TWA (as F) United Kingdom, WEL - STEL: (listed as fluorides, inorganic): 6.2 mg/m3 STEL (as F) United States OSHA: 2.5 mg/m3 TWA (as F) (listed under Fluorides).2.5 mg/m3 TWA (as F) (listed under Fluorides).50 g/m TWA (as Pb); 30 g/m3 Action Level (as Pb. Poison - see 29 CFR 1910.10 25) (listed under Lead, inorganic compounds).
Belgium - TWA: (listed as lead, inorganic compounds): 0.15 mg/m3 (dust and fume) France - VME: (listed as fluorides): 2.5 mg/m3 VME (as F) Germany: (listed as fluorides): 2.5 mg/m3 VME (as F) Japan: (listed as lead compounds): 0.1 mg/m3 OEL (except alkyl le compounds, as Pb) Malaysia: (listed as lead, inorganic compounds): 0.05 mg/m3 TWA ( Pb) Netherlands: (listed as fluorides): 3.5 mg/m3 STEL (as F) Netherlands: (listed as lead, inorganic compounds): 0.15 mg/m3 MA (dust and smoke, as Pb) Russia: (listed as lead, inorganic compounds): 0.5 mg/m3 TWA (as Spain: (listed as lead, inorganic compounds): 0.15 mg/m3 VLA-ED ( Pb) Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves and clothing to prevent skin exposure.
Clothing:
Wear appropriate protective gloves and clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Crystals
Color: white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 600 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: hydrolysis
Specific Gravity/Density:
Molecular Formula: F4Pb
Molecular Weight: 283.19

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Strong oxidizing agents, acids, fluorine, hydrogen peroxides, calcium carbide.
Hazardous Decomposition Products:
Hydrogen fluoride gas, lead/lead oxides.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 7783-59-7 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Lead Tetrafluoride - California: carcinogen, initial date 10/1/92 (listed as Lead compounds NTP: Suspect carcinogen (listed as Lead compounds).
IARC: Group 2A carcinogen (listed as Lead, inorganic compounds).

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: LEAD COMPOUND, SOLUBLE, N.O.S.
Hazard Class: 6.1
UN Number: 2291
Packing Group: III
IMO
Shipping Name: LEAD COMPOUND, SOLUBLE, N.O.S.
Hazard Class: 6.1
UN Number: 2291
Packing Group: III
RID/ADR
Shipping Name: LEAD COMPOUND, SOLUBLE, N.O.S.
Hazard Class: 6.1
UN Number: 2291
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T
Risk Phrases:
R 61 May cause harm to the unborn child.
R 20/22 Harmful by inhalation and if swallowed.
R 33 Danger of cumulative effects.
R 62 Possible risk of impaired fertility.
Safety Phrases:
S 53 Avoid exposure - obtain special instructions
before use.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 7783-59-7: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 7783-59-7 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 7783-59-7 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

类别：有毒物品
毒性分级：高毒
可燃性危险特性：遇水产生剧毒氟化氢气体
储运特性：库房需通风、低温和干燥；应与含水物、酸类及食品分开储存和运输
灭火剂：二氧化碳、砂土

反应信息

• 作为反应物：
  描述：

  四氟化铅(IV) 在 H₂ 作用下， 以 neat (no solvent) 为溶剂， 生成 lead(II) fluoride
  参考文献：
  名称：

  Wartenberg, H. v., Zeitschrift fur Anorganische und Allgemeine Chemie

  摘要：

  DOI：
• 作为产物：
  描述：

  铀(VI)氟化物 、 lead(II) fluoride 以 neat (no solvent) 为溶剂， 生成 四氟化铅(IV)
  参考文献：
  名称：

  Gmelin Handbuch der Anorganischen Chemie, Gmelin Handbook: Pb: MVol.C1, 110, page 277 - 279

  摘要：

  DOI：
• 作为试剂：
  描述：

  苯酚 在 potassium fluoride 、 四氟化铅(IV) 、 氢氟酸 作用下， 以 二氯甲烷 为溶剂， 反应 0.5h， 以60%的产率得到4,4-difluorocyclohexadienone
  参考文献：
  名称：

  Meurs, Jan H. H.; Sopher, David W.; Eilenberg, Wolf, Angewandte Chemie, 1989, vol. 101, # 7, p. 955 - 956

  摘要：

  DOI：

文献信息

• Syntheses of Dioxygenyl Salts by Photochemical Reactions in Liquid Anhydrous Hydrogen Fluoride: X-ray Crystal Structures of α- and β-O₂Sn₂F₉, O₂Sn₂F₉·0.9HF, O₂GeF₅·HF, and O₂[Hg(HF)]₄(SbF₆)₉
  作者：Zoran Mazej、Evgeny Goreshnik

  DOI：10.1021/acs.inorgchem.9b03518

  日期：2020.2.3

  two-dimensional ([Sn2F9]-)∞ grids with [O2]+ cations and HF molecules located between them. The 2-D grids have a wavelike conformation. The ([Sn2F9]-)∞ layer contains both six- and seven-coordinated Sn(IV) atoms that are interconnected by bridging fluorine atoms. A new, more complex [O2]+ salt, O2[Hg(HF)]4[SbF6]9, was prepared. In its crystal structure, the Hg atoms bridge to SbF6 units to form a 3-D framework

  通过用UV光解的O2 / F2混合物处理气态，液体或固体氟化物，并通过在环境温度下于液态无水HF中用UV光解的F2（或O2 / F2混合物）处理固体氧化物，我们研究了制备O2MIIIF4（M = B，Fe，Co，Ag），O2MIVF5（M = Ti，Sn，Pb），（O2）2MIVF6（M = Ti，Ge，Sn，Pb，Pd，Ni，Mn），O2MIV2F9（M = Sn），O2MVF6（M = As，Sb，Au，Pt），O2MV2F11（M = Pt），O2MVIF7（M = Se），（O2）2MVIF8（M = Mo，W）和O2MVIIF8（M = I）。在先前已知的O2BF4，O2MF6（M = As，Sb，Au; Pt），O2GeF5和（O2）2（Ti7F30）的情况下，该方法已经成功。合成了新型化合物O2GeF5·HF，α- n2F9（1-D）和HF溶剂化和非溶剂化形式的β-O2S
• Photochemistry with ClF ₃ – An Access to [ClOF ₂ ] ⁺ Salts
  作者：Benjamin Scheibe、Antti J. Karttunen、Florian Kraus

  DOI：10.1002/zaac.202200106

  日期：2022.12.27

  formed salts with the respective hexafluoridometallate(IV) anion with the composition [ClOF2]2[MF6]. They crystallize in two distinct structure types in either the monoclinic crystal system (M=Cr, Rh, Ge) or the orthorhombic one (M=Pd, Pt, Sn). The fluorides SnF2 and PbF4 were converted to the monoclinic salts [ClOF2]MF5, and B2O3 formed orthorhombic [ClOF2][BF4]. The triclinic compound ([ClOF2][OsO3F3])2⋅OsF6

  描述了一种制备 [ClOF 2 ] +阳离子盐的途径，该途径不需要母体氟化物 ClOF 3作为起始材料。这些可以在金属如 Cr、Rh、Pd 和 Au，卤化物如 PtCl 2、SnF 2和 PbF 4，或氧化物如 B 2 O 3、OsO 4、GeO 2、SnO 和 Sb 2 O 4时获得必要时在紫外线照射下与 ClF 3和额外的 O 2反应。Cr, Rh, Pd, PtCl 2 , GeO 2, 和 SnO 分别与组成为 [ClOF 2 ] 2 [ M F 6 ] 的六氟金属酸盐 (IV) 阴离子形成盐。它们在单斜晶系（M =Cr、Rh、Ge）或正交晶系（M =Pd、Pt、Sn）中以两种不同的结构类型结晶。氟化物SnF 2和PbF 4转化为单斜晶盐[ClOF 2 ] M F 5，B 2 O 3形成正交晶[ClOF 2 ][BF 4 ]。三斜晶系化合物 ([ClOF 2 ][OsO 3F 3 ])
• Gmelin Handbuch der Anorganischen Chemie, Gmelin Handbook: Pb: MVol.C1, 125, page 307 - 309
  作者：

  DOI：——

  日期：——
• Gmelin Handbuch der Anorganischen Chemie, Gmelin Handbook: F: MVol., 1, page 1 - 3
  作者：

  DOI：——

  日期：——
• Gmelin Handbuch der Anorganischen Chemie, Gmelin Handbook: Pb: MVol.C2, 110, page 580 - 582
  作者：

  DOI：——

  日期：——